Table 1 Baseline characteristics of patients
Non-prior vascular disease (n = 156) | |
|---|---|
Age (years) | 66.1 (10.4) |
Male sex (%) | 102 (65.4%) |
Body mass index (Kg/m2) | 28.7 (4.0) |
Hypertension | 93 (59.6%) |
Hypercholesterolemia | 91 (58.3%) |
DM | 41 (26.3%) |
Smoking habit | 68 (43.6%) |
Family history of premature CAD | 22 (14.1%) |
SCORE | |
Low | 10 (6.4%) |
Moderate | 52 (33.3%) |
High | 47 (30.1%) |
Very high | 45 (28.8%) |
Chest pain | 149 (95.5%) |
Typical | 82 (55.0%) |
Atypical | 65 (43.6%) |
Non-anginal | 2 (1.3%) |
FPG levels (mg/dL) | 114.3 (33.5) |
GFR (ml//min/1.73 m2) | 78.3 (24.0) |
Total Cholesterol levels (mg/dL) | 189.2 (44.7) |
Low-density lipoprotein levels (mg/dL) | 114.4 (38.5) |
High-density lipoprotein levels (mg/dL) | 44.1 (11.7) |
Triglyceride levels (mg/dL) | 159.1 (94.1) |
Drugs prior EE | |
Beta-blockers | 36 (23.1%) |
Calcium channel blockers | 40 (25.6%) |
Nitrates | 23 (14.7%) |
Statins | 68 (43.6%) |
Antiplatelet drugs | 51 (32.7%) |
EE data | |
Systolic BP (mmHg) | |
Rest | 141.5 (20.3) |
Peak | 184.9 (29.3) |
Heart rate (beats/min) | |
Rest | 69.9 (13.1) |
Peak | 131.6 (18.6) |
Rate-pressure (× 103 mmHg beats/min) | |
Rest | 9.9 (2.5) |
Peak | 24.4 (5.6) |
Exercise time (min) | 6.9 (2.7) |
Positive EE | 93 (59.6%) |
Negative EE | 38 (24.4%) |
Failure to achieve submaximal predicted heart rate | 25 (16.0%) |
Metabolic equivalents | 7.5 (2.6) |
Left ventricular ejection fraction (%) | |
Rest | 62.5 (7.1) |
Peak | 64.3 (12.4) |
Resting wall motion abnormality | 21 (13.6%) |
Wall motion score index | |
Rest | 1.04 (0.17) |
Peak | 1.22 (0.28) |
Carotid ultrasound data | |
Mean CIMT (mm) | 0.88 (0.19) |
Mean CIMT percentile Spanish population | |
≤ 25th | 18 (11.5%) |
25th - 75th | 40 (25.6%) |
≥ 75th | 98 (62.8%) |
CP | 95 (60.9%) |
Calcified CP | 47 (30.5%) |